Company: PETVW
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001493152-25-006783
Chunk: 34

Company: PetVivo Holdings, Inc.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part I, Item 1
Chunk 34
---
,000)
    shares returned in October 2023 from a service provider for cancellation of consulting agreement valued at $537,500;

    xxi)
    600,000
    shares in November 2023 sold pursuant to the At The Market (ATM) agreement. Proceeds from the sale was $870,000 less offering expenses
    of $63,107 to arrive at net proceeds of $806,893;

    xxii)
    133,666
    shares in October 2023 to service providers for consulting services valued at market on the date of grant of $255,305;

    xxiii)
    1,250
    shares related to vesting of RSUs in October 2023;

    xxiv)
    16,666
    shares in November 2023 to service providers for consulting services valued at market on the date of grant of $23,747;

    xxv)
    16,672
    shares in December 2023 to service providers for consulting services valued at market on the date of grant of $14,071;

    xxvi)
    352,224
    shares in connection with the sale of stock in December 2023 in exchange for proceeds of $290,000;

    xxvii)
    74,000
    shares in December 2023 pursuant to the ATM. Proceeds from the sale were $89,033 less offering expenses of $2,672 to arrive at net
    proceeds of $86,361; and

    xxviii)
    10,000
    shares related to vesting of RSUs in December 2023.

    23

The
Company has issued shares of common stock to providers of investor relations services which are reported in the Consolidated Statements
of Changes in Stockholders’ Equity. The value of these shares is reported as a prepaid expense and are amortized to expense over
the contractual life of the respective consulting agreements. The amortization of stock issued for services as reported in the Consolidated
Statements of Operations and Cash Flows was $626,653 and $629,554 for the nine months ended December 31, 2024, and 2023, respectively.

Preferred
Stock

For
the nine months ended December 31, 2024, the Company issued 3,045,000 shares of series A convertible preferred stock in exchange for
proceeds of $1,218,000 at a price of $0.40